{"entity":{"id":"nct04305795","kind":"trial","name":"An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors","aka":[],"tldr":"A phase 1/2 trial of Pembrolizumab and Cemiplimab in head and neck squamous cell carcinoma and cutaneous squamous cell carcinoma, run by Rakuten Medical, Inc., active and no longer recruiting.","summary":"An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT04305795 by Rakuten Medical, Inc., with 23 participants enrolled, started 2020-12-21 and due to reach its primary completion in 2026-06. Interventions recorded: 200 mg Pembrolizumab, 350 mg Cemiplimab and ASP-1929 PIT.","status":"active","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT04305795","url":"https://clinicaltrials.gov/study/NCT04305795"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["head-and-neck","cutaneous-scc"],"sections":[],"technologies":[],"targets":[],"drugs":["pembrolizumab","cemiplimab"],"companies":["rakuten-medical"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT04305795","phase":"1/2","setting":"An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors","sponsor":"Rakuten Medical, Inc.","enrolled":23,"outcomes":[]},"route":"/trials/nct04305795/","neighbours":{"cancer":[{"id":"cutaneous-scc","kind":"cancer","name":"Cutaneous squamous cell carcinoma","route":"/cancers/cutaneous-scc/"},{"id":"head-and-neck","kind":"cancer","name":"Head and neck squamous cell carcinoma","route":"/cancers/head-and-neck/"}],"drug":[{"id":"cemiplimab","kind":"drug","name":"Cemiplimab","route":"/drugs/cemiplimab/"},{"id":"pembrolizumab","kind":"drug","name":"Pembrolizumab","route":"/drugs/pembrolizumab/"}],"company":[{"id":"rakuten-medical","kind":"company","name":"Rakuten Medical","route":"/companies/rakuten-medical/"}]}}